By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ritter Pharmaceuticals, Inc. 

1801 Century Park East
Suite 1820
Los Angeles  California  90067  U.S.A.
Phone: 310-203-1000 Fax: 310-919-1600


SEARCH JOBS


Industry
Pharmaceutical






Company News
Ritter Pharmaceuticals, Inc. Announces Collaboration With University of British Columbia To Explore Development Of Microbiome Therapeutics In Environmental Enteropathy 2/14/2017 6:55:23 AM
Ritter Pharmaceuticals, Inc. To Ring Today's Nasdaq Stock Market Closing Bell To Kick-off Lactose Intolerance Awareness Month 1/31/2017 7:14:16 AM
Ritter Pharmaceuticals, Inc. Release: Company Announces Collaboration With University of Nebraska To Explore Development Of Microbiome Therapeutics In Metabolic Syndrome 1/23/2017 10:15:21 AM
Ritter Pharmaceuticals, Inc. Appoints William Merino, Ph.D., To Its Board Of Directors 1/17/2017 11:11:50 AM
Ritter Pharmaceuticals, Inc. Phase 2a Lactose Intolerance Clinical Trial Microbiome Data, Published In PNAS 1/4/2017 10:27:47 AM
Ritter Pharmaceuticals, Inc. Reports Third Quarter 2016 Financial Results And Provides Business Update 11/7/2016 12:51:36 PM
Ritter Pharmaceuticals, Inc. Prices $5,000,000 Public Offering Of Common Stock 10/26/2016 12:02:57 PM
Ritter Pharmaceuticals, Inc. Announces Proposed Public Offering Of Common Stock 10/26/2016 11:54:28 AM
Ritter Pharmaceuticals, Inc. Concludes Last Patient Visit Of Its Phase 2b/3 Clinical Trial Of RP-G28 For The Treatment Of Lactose Intolerance 10/18/2016 7:21:24 AM
Ritter Pharmaceuticals, Inc. Presents At The 4th Microbiome R&D Business Collaboration Forum 10/6/2016 1:01:35 PM
12345
//-->